E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/25/2022 in the Prospect News High Yield Daily.

Mallinckrodt moves up; Endo senior notes weaken; Bed Bath & Beyond lower; CURO declines

By Cristal Cody

Tupelo, Miss., May 25 – Distressed pharmaceutical paper went out mixed on Wednesday in mostly light secondary market action.

Mallinckrodt plc’s 5½% senior notes due 2025 climbed 3¾ points to 39 bid on $2 million of volume, a source said.

Endo International plc’s 6% senior notes due 2028 (Caa3/CC) were down ¾ point and trading with an 8 bid handle.

Volume was on the light side with $1 million of supply seen.

In other issues active on Wednesday, CURO Group Holdings Corp.’s 7½% senior secured notes due August 2028 (Caa1/CCC+) dropped 1 point to 71¾ bid on light trading totaling $1 million, a market source said.

The issue priced nearly a year ago at par.

Bed Bath & Beyond Inc.’s 3.749% senior notes due 2024 (B3/B+) also shed ¾ point over the session to 70 bid, a source said.

The issue saw $3 million of volume.

Elsewhere, S&P Global Ratings said in a report on Wednesday that downgrade risks for 2023 are building from the impact of interest rate and EBITDA stresses on U.S. speculative-grade companies.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.